Study: Soy Germ Isoflavones Reduce Bone Loss

Study: Soy Germ Isoflavones Reduce Bone Loss A new study published in this month's European Journal of Nutrition demonstrates a strong correlation between reducing bone loss in non-obese postmenopausal women and the dose-dependent effect of soy germ isoflavones.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales New Research Indicates That Natural Pine Bark Extract Relieves Muscle Cramp And Pain Two studies, with a total of 113 participants indicate that Pycnogenol significantly reduces muscular pain and cramps in athletes and healthy, normal individuals. New Research Indicates That Natural Pine Bark Extract Relieves Muscle Cramp And Pain Two studies, with a total of 113 participants indicate that Pycnogenol significantly reduces muscular pain and cramps in athletes and healthy, normal individuals. New Research Indicates That Natural Pine Bark Extract Relieves Muscle Cramp And Pain Two studies, with a total of 113 participants indicate that Pycnogenol significantly reduces muscular pain and cramps in athletes and healthy, normal individuals. New Research Indicates That Natural Pine Bark Extract Relieves Muscle Cramp And Pain Two studies, with a total of 113 participants indicate that Pycnogenol significantly reduces muscular pain and cramps in athletes and healthy, normal individuals. Triarco Clinical Trial Indicates Aminogen® Boosts Branched-Chain Amino Acids Over 250% Triarco Clinical Trial Indicates Aminogen® Boosts Branched-Chain Amino Acids Over 250% Triarco Clinical Trial Indicates Aminogen® Boosts Branched-Chain Amino Acids Over 250% Triarco Clinical Trial Indicates Aminogen® Boosts Branched-Chain Amino Acids Over 250% Triarco Clinical Trial Indicates Aminogen® Increases Nitrogen Retention By 32%! Triarco clinical trial studied Aminogen’s impact on nitrogen balance, in subjects taking the patented enzyme formula with their whey protein. Nitrogen excretion and retention levels were measured every 4 hours over a 24-hour period. Triarco Clinical Trial Indicates Aminogen® Increases Nitrogen Retention By 32%! Triarco clinical trial studied Aminogen’s impact on nitrogen balance, in subjects taking the patented enzyme formula with their whey protein. Nitrogen excretion and retention levels were measured every 4 hours over a 24-hour period. Triarco Clinical Trial Indicates Aminogen® Increases Nitrogen Retention By 32%! Triarco clinical trial studied Aminogen’s impact on nitrogen balance, in subjects taking the patented enzyme formula with their whey protein. Nitrogen excretion and retention levels were measured every 4 hours over a 24-hour period. Triarco Clinical Trial Indicates Aminogen® Increases Nitrogen Retention By 32%! Triarco clinical trial studied Aminogen’s impact on nitrogen balance, in subjects taking the patented enzyme formula with their whey protein. Nitrogen excretion and retention levels were measured every 4 hours over a 24-hour period. New Study: Pine Bark Extract Reduces ADHD Symptoms In Children New randomized, double-blind placebo-controlled study to be published in the June 17 edition of the journal of European Child & Adolescent Psychiatry shows a significant reduction of Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in children after supplementing with Pycnogenol® (1 mg of Pycnogenol or placebo for every kilogram of body weight) for one month. New Study: Pine Bark Extract Reduces ADHD Symptoms In Children New randomized, double-blind placebo-controlled study to be published in the June 17 edition of the journal of European Child & Adolescent Psychiatry shows a significant reduction of Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in children after supplementing with Pycnogenol® (1 mg of Pycnogenol or placebo for every kilogram of body weight) for one month. New Study: Pine Bark Extract Reduces ADHD Symptoms In Children New randomized, double-blind placebo-controlled study to be published in the June 17 edition of the journal of European Child & Adolescent Psychiatry shows a significant reduction of Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in children after supplementing with Pycnogenol® (1 mg of Pycnogenol or placebo for every kilogram of body weight) for one month. New Study: Pine Bark Extract Reduces ADHD Symptoms In Children New randomized, double-blind placebo-controlled study to be published in the June 17 edition of the journal of European Child & Adolescent Psychiatry shows a significant reduction of Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in children after supplementing with Pycnogenol® (1 mg of Pycnogenol or placebo for every kilogram of body weight) for one month. New Studies Focus On Lignans and Breast Health Study conducted in Germany and published this month in the European Journal of Cancer Prevention, reported that women who had a higher lignan intake decreased their risk of breast cancer by 58 percent. A study in progress in Australia is investigating the effects of a flax lignan extract, LinumLife® EXTRA on markers of breast health in postmenopausal women. New Studies Focus On Lignans and Breast Health Study conducted in Germany and published this month in the European Journal of Cancer Prevention, reported that women who had a higher lignan intake decreased their risk of breast cancer by 58 percent. A study in progress in Australia is investigating the effects of a flax lignan extract, LinumLife® EXTRA on markers of breast health in postmenopausal women. New Studies Focus On Lignans and Breast Health Study conducted in Germany and published this month in the European Journal of Cancer Prevention, reported that women who had a higher lignan intake decreased their risk of breast cancer by 58 percent. A study in progress in Australia is investigating the effects of a flax lignan extract, LinumLife® EXTRA on markers of breast health in postmenopausal women. New Studies Focus On Lignans and Breast Health Study conducted in Germany and published this month in the European Journal of Cancer Prevention, reported that women who had a higher lignan intake decreased their risk of breast cancer by 58 percent. A study in progress in Australia is investigating the effects of a flax lignan extract, LinumLife® EXTRA on markers of breast health in postmenopausal women. Meta-Analysis Confirms Venaforce Horse Chestnut Extract To Be Effective for CVI Study appeared in the journal, Advances in Therapy, Jan/Feb, 2006 - shown in meta-analysis of five studies to be effective in reducing the symptoms associated with chronic venous insufficiency, such as lower leg swelling. Meta-Analysis Confirms Venaforce Horse Chestnut Extract To Be Effective for CVI Study appeared in the journal, Advances in Therapy, Jan/Feb, 2006 - shown in meta-analysis of five studies to be effective in reducing the symptoms associated with chronic venous insufficiency, such as lower leg swelling. Plants Help Fight Cardiovascular Disorders On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition. Plants Help Fight Cardiovascular Disorders On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition. Plants Help Fight Cardiovascular Disorders On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition. Plants Help Fight Cardiovascular Disorders On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition. Plants Help Fight Cardiovascular Disorders On the occasion of the XIV International Symposium on Atherosclerosis in Rome, Paolo Morazzoni, President of the Scientific Board of Indena, is to give a Master Lecture on how standardised extracts of edible plants can be used to optimise nutrition. Web Site Detailing Zeaxanthin Science Adds New Pola Group Study Company presents comprehensive, easily accessible abstract collection is readily available on the web site www.Chrysantis.com. The most recent addition is the study conducted by the Ocular Pathologies Associated with Age group. Web Site Detailing Zeaxanthin Science Adds New Pola Group Study Company presents comprehensive, easily accessible abstract collection is readily available on the web site www.Chrysantis.com. The most recent addition is the study conducted by the Ocular Pathologies Associated with Age group. Web Site Detailing Zeaxanthin Science Adds New Pola Group Study Company presents comprehensive, easily accessible abstract collection is readily available on the web site www.Chrysantis.com. The most recent addition is the study conducted by the Ocular Pathologies Associated with Age group. Web Site Detailing Zeaxanthin Science Adds New Pola Group Study Company presents comprehensive, easily accessible abstract collection is readily available on the web site www.Chrysantis.com. The most recent addition is the study conducted by the Ocular Pathologies Associated with Age group. Web Site Detailing Zeaxanthin Science Adds New Pola Group Study Company presents comprehensive, easily accessible abstract collection is readily available on the web site www.Chrysantis.com. The most recent addition is the study conducted by the Ocular Pathologies Associated with Age group. New Study Shows Cinnamon Extract Lowers Blood Sugar Levels in People with Type 2 Diabetes Placebo-controlled, double-blind study from the University of Hannover in Hannover, Germany published in a recent issue of the European Journal of Clinical Investigation, evaluated the effect of a water-soluble cinnamon extract on glycemic control and the lipid profile of Western patients with type 2 diabetes. New Study Shows Cinnamon Extract Lowers Blood Sugar Levels in People with Type 2 Diabetes Placebo-controlled, double-blind study from the University of Hannover in Hannover, Germany published in a recent issue of the European Journal of Clinical Investigation, evaluated the effect of a water-soluble cinnamon extract on glycemic control and the lipid profile of Western patients with type 2 diabetes. New Study Shows Cinnamon Extract Lowers Blood Sugar Levels in People with Type 2 Diabetes Placebo-controlled, double-blind study from the University of Hannover in Hannover, Germany published in a recent issue of the European Journal of Clinical Investigation, evaluated the effect of a water-soluble cinnamon extract on glycemic control and the lipid profile of Western patients with type 2 diabetes. CRN Risk Assessments For Non-Essential Nutrients Published The Council for Responsible Nutrition (CRN) has authored risk assessments, published by the peer-reviewed journal Regulatory Toxicology and Pharmacology, for coenzyme Q10 (CoQ10), carotenoids lutein and lycopene, and creatine monohydrate. CRN Risk Assessments For Non-Essential Nutrients Published The Council for Responsible Nutrition (CRN) has authored risk assessments, published by the peer-reviewed journal Regulatory Toxicology and Pharmacology, for coenzyme Q10 (CoQ10), carotenoids lutein and lycopene, and creatine monohydrate. New Study Demonstrates That Bifantis(TM) (Bifidobacterium infantis 35624) Offers Relief for Women With Irritable Bowel Syndrome study published in the July issue of the American Journal of Gastroenterology found that Bifantis (Bifidobacterium infantis 35624) may help relieve many of the symptoms associated with irritable bowel syndrome (IBS) in women, including diarrhea and constipation. New Study Demonstrates That Bifantis(TM) (Bifidobacterium infantis 35624) Offers Relief for Women With Irritable Bowel Syndrome study published in the July issue of the American Journal of Gastroenterology found that Bifantis (Bifidobacterium infantis 35624) may help relieve many of the symptoms associated with irritable bowel syndrome (IBS) in women, including diarrhea and constipation. New Study Demonstrates That Bifantis(TM) (Bifidobacterium infantis 35624) Offers Relief for Women With Irritable Bowel Syndrome study published in the July issue of the American Journal of Gastroenterology found that Bifantis (Bifidobacterium infantis 35624) may help relieve many of the symptoms associated with irritable bowel syndrome (IBS) in women, including diarrhea and constipation. New Study Demonstrates That Bifantis(TM) (Bifidobacterium infantis 35624) Offers Relief for Women With Irritable Bowel Syndrome study published in the July issue of the American Journal of Gastroenterology found that Bifantis (Bifidobacterium infantis 35624) may help relieve many of the symptoms associated with irritable bowel syndrome (IBS) in women, including diarrhea and constipation. New Study Demonstrates That Bifantis(TM) (Bifidobacterium infantis 35624) Offers Relief for Women With Irritable Bowel Syndrome study published in the July issue of the American Journal of Gastroenterology found that Bifantis (Bifidobacterium infantis 35624) may help relieve many of the symptoms associated with irritable bowel syndrome (IBS) in women, including diarrhea and constipation. Study Shows Pine Bark Naturally Decreases Severe Chronic Venous Insufficiency Recent findings published in the journal of Clinical and Applied Thrombosis/Hematosis show a significant symptom reduction of chronic venous insufficiency (CVI) in patients after supplementing with Pycnogenol, with Pycnogenol more effective in reducing edema (leg swelling), tight calves, skin alterations, pain during walking and swelling limbs than Daflon, a combination of diosmin and hesperidin and a commonly prescribed drug used to treat CVI. Study Shows Pine Bark Naturally Decreases Severe Chronic Venous Insufficiency Recent findings published in the journal of Clinical and Applied Thrombosis/Hematosis show a significant symptom reduction of chronic venous insufficiency (CVI) in patients after supplementing with Pycnogenol, with Pycnogenol more effective in reducing edema (leg swelling), tight calves, skin alterations, pain during walking and swelling limbs than Daflon, a combination of diosmin and hesperidin and a commonly prescribed drug used to treat CVI. Study Shows Pine Bark Naturally Decreases Severe Chronic Venous Insufficiency Recent findings published in the journal of Clinical and Applied Thrombosis/Hematosis show a significant symptom reduction of chronic venous insufficiency (CVI) in patients after supplementing with Pycnogenol, with Pycnogenol more effective in reducing edema (leg swelling), tight calves, skin alterations, pain during walking and swelling limbs than Daflon, a combination of diosmin and hesperidin and a commonly prescribed drug used to treat CVI. Study Shows Pine Bark Naturally Decreases Severe Chronic Venous Insufficiency Recent findings published in the journal of Clinical and Applied Thrombosis/Hematosis show a significant symptom reduction of chronic venous insufficiency (CVI) in patients after supplementing with Pycnogenol, with Pycnogenol more effective in reducing edema (leg swelling), tight calves, skin alterations, pain during walking and swelling limbs than Daflon, a combination of diosmin and hesperidin and a commonly prescribed drug used to treat CVI. Preliminary Data from Human Clinical Trial Shows Vectomega®, Has Positive Results in Numerous Areas of Health Preliminary findings from a recent human trial by French doctors demonstrate that 2 tablets per day of Vectomega® improve cardiovascular health by reducing cholesterol, triglycerides and increasing HDL-c in a healthy population, among other benefits. Preliminary Data from Human Clinical Trial Shows Vectomega®, Has Positive Results in Numerous Areas of Health Preliminary findings from a recent human trial by French doctors demonstrate that 2 tablets per day of Vectomega® improve cardiovascular health by reducing cholesterol, triglycerides and increasing HDL-c in a healthy population, among other benefits. Preliminary Data from Human Clinical Trial Shows Vectomega®, Has Positive Results in Numerous Areas of Health Preliminary findings from a recent human trial by French doctors demonstrate that 2 tablets per day of Vectomega® improve cardiovascular health by reducing cholesterol, triglycerides and increasing HDL-c in a healthy population, among other benefits. Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243. Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243. Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243. Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243. Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243. New Studies Indicate That Tocomin® / Tocomin® SupraBio(TM) Supplementation Elevates Blood Levels Sufficiently to Protect Against Stroke-Induced Neurodegeneration Two NIH-funded studies conducted at the Ohio State University Medical Center, published in the May, 2006 issue of the journal Antioxidant & Redox Signaling and June 26th issue of the Journal of Neurochemistry, demonstrate that taking tocotrienols (Tocomin® and Tocomin® SupraBioTM) orally is an effective way to elevate blood plasma levels to concentrations that could help protect against neurological damage resulting from stroke New Studies Indicate That Tocomin® / Tocomin® SupraBio(TM) Supplementation Elevates Blood Levels Sufficiently to Protect Against Stroke-Induced Neurodegeneration Two NIH-funded studies conducted at the Ohio State University Medical Center, published in the May, 2006 issue of the journal Antioxidant & Redox Signaling and June 26th issue of the Journal of Neurochemistry, demonstrate that taking tocotrienols (Tocomin® and Tocomin® SupraBioTM) orally is an effective way to elevate blood plasma levels to concentrations that could help protect against neurological damage resulting from stroke New Studies Indicate That Tocomin® / Tocomin® SupraBio(TM) Supplementation Elevates Blood Levels Sufficiently to Protect Against Stroke-Induced Neurodegeneration Two NIH-funded studies conducted at the Ohio State University Medical Center, published in the May, 2006 issue of the journal Antioxidant & Redox Signaling and June 26th issue of the Journal of Neurochemistry, demonstrate that taking tocotrienols (Tocomin® and Tocomin® SupraBioTM) orally is an effective way to elevate blood plasma levels to concentrations that could help protect against neurological damage resulting from stroke Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial. Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial. Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial. Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial. Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial. Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial. Reduction of Inducible Arrhythmia in Patients with Cardiovascular Disease by Fish Oil Dr. R. Metcalf presented highly original findings this morning on DHA/EPA Omega-3 fatty acids and cardiac arrhythmias from a recent pilot trial. Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging. Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging. Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging. Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging. Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging. Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. ISO14001 certification granted to Indena Indena has been granted the ISO14001 certification for its main production site of Settala (Milan). ISO14001 certification granted to Indena Indena has been granted the ISO14001 certification for its main production site of Settala (Milan). ISO14001 certification granted to Indena Indena has been granted the ISO14001 certification for its main production site of Settala (Milan). ISO14001 certification granted to Indena Indena has been granted the ISO14001 certification for its main production site of Settala (Milan). ISO14001 certification granted to Indena Indena has been granted the ISO14001 certification for its main production site of Settala (Milan). New Company for “Change-The-World” Entrepreneurs™ Launches	Supplementation with SoyLife® EXTRA decreased bone loss in postmenopausal women Minneapolis – A new study published in this month's European Journal of Nutrition demonstrates a strong correlation between reducing bone loss in non-obese postmenopausal women and the dose-dependent effect of soy germ isoflavones, particularly SoyLife®. These findings support previous scientific findings regarding soy isoflavones for post-menopausal women. According to the authors of the study, "Osteoporosis is a health condition experienced by about one in three postmenopausal women, with estrogen deficiency often acting as the major cause. Hormone replacement therapy has been the most effective treatment for maintaining bone density. This treatment often has adverse side effects such as an increased risk for endometrial cancer and breast cancer." "It is imperative to find natural, safe and effective alternatives for women to help maintain bone health after menopause – without the risky side effects associated with long-term hormone replacement therapy use. This promising research is another step in advancing soy germ isoflavones as a safe, effective option," said Jocelyn Mathern, RD and Technical Specialist, Acatris. The study aimed to examine the effects of a high-dose supplementation of soy germ isoflavones (84 and 126 mg SoyLife® EXTRA/day) in slowing bone loss in 90 early postmenopausal Chinese women. Isoflavones are found predominately in soy products. Their structure and functions are similar to estrogen, and observational studies suggest that higher intakes of soy and soy products may lower the prevalence of osteoporosis. Soy isoflavones have been supported by proprietary scientific studies to promote women's health, bone health, heart health, prostate health and cognitive function. A focus of the study, SoyLife® is a range of ingredients from soy germ, rich in isoflavones. More than just an isoflavone concentrate, SoyLife® offers the complete spectrum of natural soy compounds, the Soy MatrixTM, which enhances the bio-availability of isoflavones. "In addition to this research, more studies are examining the effects of either soy or isoflavones on bone density in humans," said Mathern. "We are awaiting results of a large study, the Osteoporosis Prevention Using Soy (OPUS) study, a multi-site, two year research study on the use of soy isoflavones to prevent bone loss in 400 postmenopausal women. Both this current study and OPUS used SoyLife®, and we're excited to see SoyLife® helping lead the way in determining the required dosage of soy isoflavones for safely decreasing bone loss and preventing osteoporosis in postmenopausal women." Another recent study published in the journal of Fertility and Sterility demonstrated soy isoflavones' effectiveness and key role in improving mood and cognitive function in postmenopausal women. This research strongly points to soy isoflavone supplementation as a natural, effective way to significantly improve the quality of life for postmenopausal women. ### Acatris, division of the Dutch Royal Schouten Group, is an international organization that produces, markets and distributes ingredients for the food, health and nutrition industry. The product portfolio contains branded ingredients such as SoyLife®, FenuLife® and LinumLife®.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software